Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2016 Aug 22;25(11):1503–1510. doi: 10.1158/1055-9965.EPI-16-0147

Table 1.

Association between body mass index (BMI) and endometrial cancer risk overall, and for endometrioid and non-endometrioid histologies1

Controls All cases Endometrioid cases Non-endometrioid cases
BMI2
Category
N (%) N (%) OR (95% CIs) N (%) OR (95% CIs) N (%) OR (95% CIs)
<25kg/m2 7146 (45%) 1159 (28%) Reference 964 (28%) Reference 195 (32%) Reference
25–29.9 5628 (35%) 1252 (31%) 1.06 (0.65–1.70) 1053 (30%) 1.05 (0.64–1.72) 199 (33%) 1.27 (1.07–1.48)
30–34.9 2213 (14%) 795 (19%) 1.60 (0.95–2.71) 684 (20%) 1.62 (0.94–2.80) 111 (18%) 1.88 (1.64–2.12)
35–39.9 693 (4%) 472 (12%) 3.522(2.35–4.43) 413 (12%) 3.26 (2.31–4.61) 59 (10%) 3.16 (2.85–3.48)
≥40 294 (2%) 409 (10%) 6.10 (3.67–10.17) 366 (10%) 6.26 (3.55–11.06) 43 (7%) 5.92 (5.56–6.27)
Ptrend3 1.8×10−26 1.7×10−17 1.42×10−27
Per 5kg/m2 increase in EC
risk
1.55 (1.44–1.68) 1.56 (1.42–1.72) 1.50 (1.43–1.57)
1

Random effects model.

2

BMI range: Overall 15.24–75.00 (mean 27.18, SD 5.72); Cases 15.24–75.00 (mean 29.86, SD 7.45)’ Controls 15.94–67.90 (mean 26.52, SD 4.99).

3

Tests for heterogeneity: All cases I2=73.4%, Q=7.53, P=0.02; Endometrioid cases I2=81.1%, Q=10.57, P=0.005. Non-endometrioid cases are from the iCOGs dataset only and were not meta-analyzed.